Indaptus Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 14 Aug 23 | BuyUS$216,388 | Glen Anderson | Individual | 103,352 | US$2.34 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 4,066 | 0.0476% |
| Institutions | 569,513 | 6.67% |
| Individual Insiders | 2,636,100 | 30.9% |
| General Public | 5,329,204 | 62.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 1,368,356 | US$3.2m | 0% | no data | |||
| 1,190,400 | US$2.8m | 0% | no data | |||
| 256,265 | US$602.2k | 0% | no data | |||
| 102,437 | US$240.7k | 0% | 0.01% | |||
| 75,374 | US$177.1k | 0% | no data | |||
| 54,767 | US$128.7k | 0% | no data | |||
| 45,336 | US$106.5k | 0% | 0.02% | |||
| 44,145 | US$103.7k | -0.21% | 0.01% | |||
| 26,100 | US$61.3k | -11.2% | no data | |||
| 24,000 | US$56.4k | 0% | 0.02% | |||
| 13,073 | US$30.7k | -32.9% | no data | |||
| 4,066 | US$9.6k | -13.4% | no data | |||
| 1,936 | US$4.5k | -47.7% | no data | |||
| 1,150 | US$2.7k | 0% | no data | |||
| 884 | US$2.1k | 0% | no data | |||
| 670 | US$1.6k | 0% | no data | |||
| 400 | US$939.1 | 0% | no data | |||
| 150 | US$353.2 | 0% | no data | |||
| 64 | US$150.5 | 0% | no data | |||
| 43 | US$100.3 | 0% | no data | |||
| 41 | US$96.3 | 2.5% | no data | |||
| 14 | US$32.1 | 55.6% | no data | |||
| 7 | US$16.1 | 0% | no data | |||
| 1 | US$2.0 | 0% | no data |